(Q41139162)

reason for preferred rank

27 September 2017

Alternating versus hybrid MOPP-ABVD in Hodgkin’s disease: The Milan experience (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

5 November 2022

Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710921

5 November 2022

1

S. Viviani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710921

5 November 2022

author name string

G. Bonadonna

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710921

5 November 2022

A. Santoro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710921

5 November 2022

M. Zanini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710921

5 November 2022

R. Zucali

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710921

5 November 2022

E. Negretti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710921

5 November 2022

P. Valagussa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710921

5 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1710921

5 November 2022

publication date

1 February 1991

1 reference

full work available at URL

27 September 2017

http://link.springer.com/content/pdf/10.1007/978-1-4899-7305-4_9

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

5 November 2022

1 reference

27 September 2017

2 Suppl 2

1 reference

27 September 2017

55-62

1 reference

Alternating drug combinations in the treatment of advanced Hodgkin's disease

27 September 2017

2

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience

5 November 2022

3

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.

5 November 2022

4

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

Influence of clinical trials on current treatment strategy for Hodgkin's disease

5 November 2022

5

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

5 November 2022

Cancer Treatment Reports

6

63

1727

JH Goldie

1979

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

5 November 2022

Cancer Treatment Reports

7

66

439

JH Goldie

1982

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

The James Ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer.

5 November 2022

9

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

5 November 2022

Cancer Treatment Reports

11

68

43

HE Skipper

1984

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

5 November 2022

12

4

438

G Bonadonna

1985

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

5 November 2022

13

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

High dose chemo-radiotherapy for sensitive tumors: is sequential better than concurrent drug delivery?

5 November 2022

15

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

5 November 2022

16

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-7305-4_9

5 November 2022

Identifiers

10.1093/ANNONC/2.SUPPL_2.55

1 reference

27 September 2017

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1710921

release_3ouwszjlbvbojeki23vvw3ia2e

5 November 2022

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3ouwszjlbvbojeki23vvw3ia2e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference